Mechanisms of Choroidal Blood Flow Changes During Dark/Light Transitions

NCT00431392 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Regional Blood Flow
Ocular Physiology

Interventions

DRUG: Phenylephrine
DRUG: NG-Monomethyl-L-Arginine
DRUG: Propanolol
DRUG: Atropine

Sponsor

Medical University of Vienna